Skip to main content
Log in

Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins

  • Original Papers
  • Published:
Archives of gynecology Aims and scope Submit manuscript

Summary

Twenty-six peri- and postmenopausal women with climacteric symptoms were given each day for 1 year a tablet containing 2 mg 17-β-estradiol, 1 mg estriol and 1 mg norethisterone acetate. Blood samples were collected before, after 3 months and after 12 months of treatment and were analysed for their gonadotrophins, estradiol, estrone, testosterone, androstenedione content and for their SHBG binding capacity.

Serum levels of estrone and androstenedione before treatment were found to be higher in the perimenopausal than in the postmenopausal group. An increase of serum estrogens concomitant with a decrease of gonadotrophins was noted. The estrone/estradiol ratios after 3 and 12 months of treatment were 5.3 and 4.7, respectively. A decrease in the serum concentration of testosterone and androstenedione was recorded during treatment. The reduction of gonadotrophins, especially LH, might have been responsible for the reduction in circulating androgens. The reduction of serum levels of androgens during the present long-term replacement therapy could be of metabolic importance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson DC (1974) Sex hormone binding globulin. Clin Endocrinol 3: 69–96

    Google Scholar 

  2. Bengtsson C, Lindquist O, Redvall L (1980) Menstrual status and menopausal age of middle-aged Swedish women. Acta Obstet Gynecol Scand 60: 269–275

    Google Scholar 

  3. Burr IM, Grant DB, Sizonenko PC, Kaplan SL, Grumbach MM (1969) Some critical factors in double antibody radioprecipitating sera for measurement of human LH, FSH and HGH. J Clin Endocrinol Metab 29: 948–956

    PubMed  Google Scholar 

  4. Campbell S, Minardi J, McQueen J, Whitehead MI (1978) The modifying effect of progestogen on the response of the postmenopausal endometrium to exogenous estrogens. Postgrad Med [Suppl 2] 54: 59–64

    Google Scholar 

  5. Cullberg G, Knutsson F, Lindstedt G, Mattsson L-Å, Steffensen K (1982) Ethinylestradiol and a new progestogen (desogestrel) in a low dose combination: Effects on pituitary-gonadal function, serum sex-hormone binding globulin capacity, endometrium and cervical mucus. Acta Obstet Gynecol Scand [Suppl] 111: 29–38

    Google Scholar 

  6. Dada OA, Laumas V, Landgren B-M, Cekan SZ, Diczfalusy E (1978) Effect of graded oral doses of estradiol on circulating hormonal levels. Acta Endocrinol (Copenh) 88: 754–767

    Google Scholar 

  7. Dennis M, Horst HJ, Krieg M, Voigt KD (1977) Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: Comparison with age dependent rise in normal human males. Acta Endocrinol (Copenh) 84: 207–214

    Google Scholar 

  8. Englund DE, Johansson EDB (1978) Plasma levels of estrone, estradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine estrogens (Premarin). Brit J Obstet Gynecol 85: 957–964

    Google Scholar 

  9. Franchimont P, Cessions G, Ayalon D, Musters A, Legros JJ (1970) Suppressive action of norethisterone enanthate and acetate on gonadotrophin (FSH and LH) levels. Obstet Gynecol 36: 93–100

    PubMed  Google Scholar 

  10. Gambrell RD Jr, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA, Wright JM (1980) Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 55: 732–738

    PubMed  Google Scholar 

  11. Greenblatt RB, Colle ML, Mahesh VB (1976) Ovarian and adrenal steroid production in the postmenopausal women. Obstet Gynecol 47: 383–387

    PubMed  Google Scholar 

  12. Helgason S, Damber J-E, Damber M-G, von Schoultz B, Selstam G, Södergård R (1982) A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapy. Acta Obstet Gynecol Scand 61: 97–100

    PubMed  Google Scholar 

  13. Ismail AAA, Niswender GD, Midgley AR Jr (1972) Radioimmunoassay of testosterone without chromatography. J Clin Endocrinol Metab 34: 177–184

    PubMed  Google Scholar 

  14. Lagrelius A, Carlström K, Lunell NO (1981) Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. Acta Obstet Gynecol Scand 60: 33–38

    PubMed  Google Scholar 

  15. Longcope C (1974) Steroid production in pre- and postmenopausal women. In: Greenblatt RB, Mahesh VB, McDonough PG (eds) The menopausal syndrome. Medcom Press, New York, pp 6–11

    Google Scholar 

  16. Mattsson L-Å, Cullberg G, Samsioe G (1982) Evaluation of a continuous estrogen-progestogen regimen for climacteric complaints. Maturitas 4: 95–102

    Article  PubMed  Google Scholar 

  17. Mikhail G, Wu CH, Ferin M, Van de Wiele RL (1970) Radioimmunoassay of plasma estrone and estradiol. Steroids 15: 333–352

    Article  PubMed  Google Scholar 

  18. Odlind V, Weiner E, Victor A, Johansson EDB (1980) Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol 87: 416–421

    PubMed  Google Scholar 

  19. Parker LP, Grover PK, Odell ND (1977) An improved radioimmunoassay for 4-androsten-3, 17-dione. Steroids 29: 715–724

    Article  PubMed  Google Scholar 

  20. Rose DP, Fern M, Liskowski L, Milbrath JR (1977) Effect of treatment with estrogen conjugates on endogenous plasma steroids. Obstet Gynecol 49: 80–82

    PubMed  Google Scholar 

  21. Ryan KJ, Engel LL (1953) The interconversion of estrone and estradiol by human tissue slices. Endocrinology 52: 287–291

    PubMed  Google Scholar 

  22. Sexton L, Lenton EA, Anderton KJ, Brooke LM, Cooke ID (1978) The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in postmenopausal women. Postgrad Med J [Suppl 2] 54: 42–46

    PubMed  Google Scholar 

  23. Siddle NC, Townsend PT, Young O, Minardi J, King RJB, Whitehead MI (1982) Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized postmenopausal endometrium. Acta Obstet Gynecol Scand [Suppl] 106: 17–22

    Google Scholar 

  24. Sipinen S (1979) Plasma estrone, estradiol and gonadotrophin concentrations in postmenopausal patients treated with estradiol or with a combination of estradiol and estriol. Research 11: 172–178

    Google Scholar 

  25. Strecker JR, Lauritzen C, Goessens L (1979) Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause. Maturitas 1: 183–190

    Article  PubMed  Google Scholar 

  26. Thom MH, White PJ, Williams RM, Sturdee DW, Peterson MEL, Wade-Evans T, Studd JWW (1979) Prevention and treatment of endometrial disease in climacteric women receiving estrogen therapy. Lancet 1: 455–457

    Article  PubMed  Google Scholar 

  27. Yen SSC, Martin PL, Burnier AM, Czekala NM, Greaney MO Jr, Callantine MR (1975) Circulating estradiol, estrone and gonadotrophin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol 40: 518–521

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattsson, L.Å., Abrahamsson, L., Cullberg, G. et al. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins. Arch. Gynecol. 233, 101–107 (1983). https://doi.org/10.1007/BF02114786

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02114786

Key words

Navigation